Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 4
Submit an article Journal homepage
247
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Concurrent JAK2 V617F and MPL W515L in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Matthew T. YeDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Yi WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; ;Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing, China;
,
Sa A. WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Naveen PemmarajuDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Naval DaverDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Srdan VerstovsekDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Yizhuo ZhangDepartment of Pediatric Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China
,
Zhuang ZuoDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
L. Jeffrey MedeirosDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
&
M. James YouDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
 show all
Pages 963-966 | Received 16 Oct 2019, Accepted 29 Oct 2019, Published online: 21 Nov 2019

References

  • Lasho TL, Pardanani A, McClure RF, et al. Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time. Br J Haematol. 2006;135(5):683–687.
  • McGaffin G, Harper K, Stirling D, et al. JAK2 V617F and CALR mutations are not mutually exclusive: findings from retrospective analysis of a small patient cohort. Br J Haematol. 2014;167(2):276–278.
  • Xu N, Ding L, Yin C, et al. A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients. Ann Hematol. 2015;94(5):865–867.
  • Xing CY, Li HY, Wu JB, et al. Co-occurrence of JAK2 V617F and an uncommon CALR del (p.K368fs*51) mutation facilitates JAK2/STAT signaling in polycythemia vera. Leuk Lymphoma. 2016;57(7):1743–1745.
  • De Roeck L, Michaux L, Debackere K, et al. Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients. Hematology. 2018;23(10):785–792.
  • Usseglio F, Beaufils N, Calleja A, et al. Detection of CALR and MPL mutations in low allelic burden JAK2 V617F essential thrombocythemia. J Mol Diagn. 2017;19(1):92–98.
  • Boddu P, Chihara D, Masarova L, et al. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms. Ann Hematol. 2018;97(11):2071–2080.
  • Haunstrup LM, Ebbesen LH, Hansen M, et al. Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation. Exp Hematol. 2018; 68:62–65.
  • Mansier O, Luque Paz D, Lanotto J, et al. Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloprolifeartive neoplasms (FIM) study. Am J Hematol. 2018;93(4):E84–E86.
  • Schulze S, Stengel R, Jaekel N, et al. Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F- and MPLW515L-positive myelofibrosis. Genes Chromosomes Cancer. 2019;58(11):747–755.
  • Patnaik MM, Tefferi A. Refractory anemia with ring sideroblasts (RARS) and RARS with trhombocytosis: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94(4):475–488.
  • Tefferi A, Pardanani A. Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 2015;1(1):97–105.
  • Rotunno G, Mannarelli C, Guglielmelli P, et al. Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood. 2014;123(10):1552–1555.
  • Vannucchi AM, Antonioli E, Guglielmelli P, et al. Characteristics and clinical correlates of MPL 515W > L/K mutation in essential thrombocythemia. Blood. 2008;112(3):844–847.
  • Mansier O, Migeon M, Etienne G, et al. JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens. Leuk Lymphoma. 2016;57(8):1949–1951.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.